Brandes Investment Partners, Lp

Source: SEC Form 13F · as of Mar 2026

Brandes Investment Partners, Lp holds 21 biotech & pharma companies tracked by BioSniper, totaling $1.99B in value as of Mar 2026 (SEC Form 13F).

Companies held

21

Total value held

$1.99B

CompanySharesValue
GRFSGrifols S.A.36,333,714$291.4M
MRKMerck & Co., Inc.2,302,562$277.0M
PFEPFIZER INC9,107,225$255.7M
SNYSanofi3,723,100$179.4M
UNHUnitedHealth Group Incorporated Common Stock (DE)621,884$168.3M
ICLRICON plc1,435,053$158.8M
MCKMcKesson Corporation172,487$149.3M
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)4,430,642$82.1M
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)1,453,002$80.2M
JNJJOHNSON & JOHNSON279,660$68.4M
ELANElanco Animal Health Inc2,778,908$66.5M
CAHCardinal Health Inc.257,924$54.5M
PBHPrestige Consumer Healthcare Inc.854,119$50.6M
FMSFresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)1,610,849$36.3M
NVSNovartis AG189,570$29.0M
UTMDUtah Medical Products Inc.449,279$27.9M
ZBHZimmer Biomet Holdings Inc.59,440$5.4M
IQVIQVIA Holdings Inc.29,496$5.0M
OGNOrganon & Co.691,625$4.1M
UTHRUNITED THERAPEUTICS Corp4,281$2.5M
SHCSotera Health Company168,223$2.4M

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Brandes Investment Partners, Lp — Biotech 13F Holdings & Portfolio | BioSniper